BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 32701569)

  • 1. Disparities in Surgical Recommendation for Stage I Non-Small Cell Lung Cancer.
    Rapp JL; Tuminello S; Alpert N; Flores RM; Taioli E
    Am J Clin Oncol; 2020 Oct; 43(10):741-747. PubMed ID: 32701569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Racial Differences in Treatment and Survival among Veterans and Non-Veterans with Stage I NSCLC: An Evaluation of Veterans Affairs and SEER-Medicare Populations.
    Williams CD; Alpert N; Redding TS; Bullard AJ; Flores RM; Kelley MJ; Taioli E
    Cancer Epidemiol Biomarkers Prev; 2020 Jan; 29(1):112-118. PubMed ID: 31624076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Underperformance of Mediastinal Lymph Node Evaluation in Resectable Non-Small Cell Lung Cancer.
    Tantraworasin A; Taioli E; Liu B; Kaufman AJ; Flores RM
    Ann Thorac Surg; 2018 Mar; 105(3):943-949. PubMed ID: 29397099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment disparities for disabled medicare beneficiaries with stage I non-small cell lung cancer.
    Iezzoni LI; Ngo LH; Li D; Roetzheim RG; Drews RE; McCarthy EP
    Arch Phys Med Rehabil; 2008 Apr; 89(4):595-601. PubMed ID: 18373987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variations in Receipt of Curative-Intent Surgery for Early-Stage Non-Small Cell Lung Cancer (NSCLC) by State.
    Sineshaw HM; Wu XC; Flanders WD; Osarogiagbon RU; Jemal A
    J Thorac Oncol; 2016 Jun; 11(6):880-9. PubMed ID: 26980472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of race on invasive staging and surgery in non-small-cell lung cancer.
    Lathan CS; Neville BA; Earle CC
    J Clin Oncol; 2006 Jan; 24(3):413-8. PubMed ID: 16365180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes after treatment of 17,378 patients with locally advanced (T3N0-2) non-small-cell lung cancer.
    Speicher PJ; Englum BR; Ganapathi AM; Onaitis MW; D'Amico TA; Berry MF
    Eur J Cardiothorac Surg; 2015 Apr; 47(4):636-41. PubMed ID: 25005840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of In-Hospital and Long-term Outcomes of Sublobar Lung Cancer Surgery by VATS and Open Techniques.
    Tuminello S; Liu B; Wolf A; Alpert N; Taioli E; Flores RM
    Am J Clin Oncol; 2018 Dec; 41(12):1149-1153. PubMed ID: 29642076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical Disparities Among Patients With Stage I Lung Cancer in the National Lung Screening Trial.
    Balekian AA; Wisnivesky JP; Gould MK
    Chest; 2019 Jan; 155(1):44-52. PubMed ID: 30056040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistence of racial disparities in early-stage lung cancer treatment.
    Wolf A; Alpert N; Tran BV; Liu B; Flores R; Taioli E
    J Thorac Cardiovasc Surg; 2019 Apr; 157(4):1670-1679.e4. PubMed ID: 30685165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety-net burden hospitals and likelihood of curative-intent surgery for non-small cell lung cancer.
    Virgo KS; Little AG; Fedewa SA; Chen AY; Flanders WD; Ward EM
    J Am Coll Surg; 2011 Nov; 213(5):633-43. PubMed ID: 21907598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disparities in the Management of Patients With Stage I Small Cell Lung Carcinoma (SCLC): A Surveillance, Epidemiology and End Results (SEER) Analysis.
    Ahmed Z; Kujtan L; Kennedy KF; Davis JR; Subramanian J
    Clin Lung Cancer; 2017 Sep; 18(5):e315-e325. PubMed ID: 28438510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Racial Disparities in Resection of Early Stage Non-Small Cell Lung Cancer: Variability Among Surgeons.
    Ezer N; Mhango G; Bagiella E; Goodman E; Flores R; Wisnivesky JP
    Med Care; 2020 Apr; 58(4):392-398. PubMed ID: 31895307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of insurance status on receipt of definitive surgical therapy and posttreatment outcomes in early stage lung cancer.
    Stokes SM; Wakeam E; Swords DS; Stringham JR; Varghese TK
    Surgery; 2018 Dec; 164(6):1287-1293. PubMed ID: 30170821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Underuse of surgical resection for localized, non-small cell lung cancer among whites and African Americans in South Carolina.
    Esnaola NF; Gebregziabher M; Knott K; Finney C; Silvestri GA; Reed CE; Ford ME
    Ann Thorac Surg; 2008 Jul; 86(1):220-6; discussion 227. PubMed ID: 18573427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Appropriateness of Surgical Approach in Black Patients with Lung Cancer-15 Years Later, Little Has Changed.
    Taioli E; Flores R
    J Thorac Oncol; 2017 Mar; 12(3):573-577. PubMed ID: 27544057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disparities in surgery for early-stage cancer: the impact of refusal.
    Rapp J; Tuminello S; Alpert N; Flores RM; Taioli E
    Cancer Causes Control; 2019 Dec; 30(12):1389-1397. PubMed ID: 31630307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Racial disparities among patients with lung cancer who were recommended operative therapy.
    Farjah F; Wood DE; Yanez ND; Vaughan TL; Symons RG; Krishnadasan B; Flum DR
    Arch Surg; 2009 Jan; 144(1):14-8. PubMed ID: 19153319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sublobar resection is equivalent to lobectomy for clinical stage 1A lung cancer in solid nodules.
    Altorki NK; Yip R; Hanaoka T; Bauer T; Aye R; Kohman L; Sheppard B; Thurer R; Andaz S; Smith M; Mayfield W; Grannis F; Korst R; Pass H; Straznicka M; Flores R; Henschke CI;
    J Thorac Cardiovasc Surg; 2014 Feb; 147(2):754-62; Discussion 762-4. PubMed ID: 24280722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of primary tumor resection on the survival of patients with stage IV extrathoracic metastatic non-small cell lung cancer: A population-based study.
    Sun Z; Sui X; Yang F; Wang J
    Lung Cancer; 2019 Mar; 129():98-106. PubMed ID: 30545693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.